US Congress Makes Another Push for Drug Pricing Regulation

July 15, 2022

With tough odds in the upcoming midterm elections in mind, Democrats in the US Senate are making another push for drug pricing regulation. The latest attempt would limit the out-of-pocket drug costs to $2,000 and let Medicare negotiate drug prices. The proposal would also let the Department of Health and Human Services (HHS) select a small set of drugs for price negotiation, beginning with 10 in 2026 and steadily increasing as time passes.

According to Lecia Bushak, “During each iteration of the pricing debate, industry groups have argued that allowing the federal government to negotiate drug prices won’t fix the bigger issues leading to high prescription drug costs in the U.S. Basically, they blame it on the middlemen: insurers and pharmacy benefit managers.”

To read more, click here.

(Source: MM+M, July 14th, 2022)

Share This Story!